Cargando…
Carrier strategies boost the application of CRISPR/Cas system in gene therapy
Emerging clustered regularly interspaced short palindromic repeat/associated protein (CRISPR/Cas) genome editing technology shows great potential in gene therapy. However, proteins and nucleic acids suffer from enzymatic degradation in the physiological environment and low permeability into cells. E...
Autores principales: | Xu, Zunkai, Wang, Qingnan, Zhong, Haiping, Jiang, Yaoyao, Shi, Xiaoguang, Yuan, Bo, Yu, Na, Zhang, Shubiao, Yuan, Xiaoyong, Guo, Shutao, Yang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190933/ https://www.ncbi.nlm.nih.gov/pubmed/37323878 http://dx.doi.org/10.1002/EXP.20210081 |
Ejemplares similares
-
Intra-Articular injection of acid-sensitive stearoxyl-ketal-dexamethasone microcrystals for long-acting arthritis therapy
por: Xu, Yang, et al.
Publicado: (2021) -
Boosting plant immunity with CRISPR/Cas
por: Chaparro-Garcia, Angela, et al.
Publicado: (2015) -
Long-acting acid-sensitive ketal-linked dexamethasone microcrystals for treating experimental autoimmune uveitis
por: Cai, Maoyu, et al.
Publicado: (2022) -
BoostMEC: predicting CRISPR-Cas9 cleavage efficiency through boosting models
por: Zarate, Oscar A., et al.
Publicado: (2022) -
CRISPR-Cas9 delivery strategies with engineered extracellular vesicles
por: Lu, Yaoyao, et al.
Publicado: (2023)